Drugs.com - FDA MedWatch Alerts

Dr. Reddy’s Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., Due to Mislabeling of Infusion Bag

Audience: Pharmacy, Health Care Professional March 13, 2025 -- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), is...

Mar 14, 2025 - 01:07
 0
Dr. Reddy’s Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., Due to Mislabeling of Infusion Bag
Audience: Pharmacy, Health Care Professional March 13, 2025 -- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), is...
Read More

Tags:

Previous Article

Fragrance Brand Ourside Turns Trademark Setback Into A Community-Building Effort

Next Article

Limited Number of Voluntary Recalls Initiated after FDA Testing of Acne Products...

Related Posts

Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension Due to Bacterial Contamination

Bionpharma Inc. Issues Voluntary Nationwide Recall of A...

Feb 9, 2025  0

Alcon Laboratories Issues Voluntary Nationwide Recall of One Lot of Systane Lubricant Eye Drops Ultra PF Due to Fungal Contamination

Alcon Laboratories Issues Voluntary Nationwide Recall o...

Feb 9, 2025  0

Baxter Issues Voluntary Nationwide Recall of One Lot of Heparin Sodium in 0.9% Sodium Chloride Injection Due to Potential for Elevated Endotoxin Levels

Baxter Issues Voluntary Nationwide Recall of One Lot of...

Feb 9, 2025  0